[The beta-hemolytic Streptococcus group A carrier state].
In this study we describe the group A streptococcal upper respiratory tract carrier state, following a clinical method based on two main elements: the presence or the absence of symptoms and the result of throat swab. Through this method we are able to decide how to face each individual clinical case.
Colombo
M
M
Divisione di Pediatria, Ospedale di Rho, MI, Italia.
Magni
L A
LA
D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D002353:Carrier State / Q000175:diagnosis* / Q000188:drug therapy; D002648:Child; D003937:Diagnosis, Differential; D006801:Humans; D010612:Pharyngitis / Q000175:diagnosis / Q000188:drug therapy; D012008:Recurrence; D013290:Streptococcal Infections / Q000175:diagnosis* / Q000188:drug therapy; D013297:Streptococcus pyogenes
D000900:Anti-Bacterial Agents